Rx Medicare

NuPathe Inc., a specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced top-line results from the pivotal Phase III clinical trial of Zelrix?, a novel transdermal patch in clinical development for the treatment of acute migraine.

Read More…

Related Posts

• Phosphagenics Announces Positive Results From Phase 1B Study Of Transdermal Oxycodone Patch
• Winston Laboratories, Inc. Announces Positive Top-line Results Of Phase II Clinical Trial Of Civamide Patch
• Alkermes Announces Positive Results For Phase 1 Study Of New Drug Candidate For Treatment Of Opioid-Induced Constipation
• AcelRx Announces Positive Results From A Phase 2 Study Of ARX-03, A Sufentanil/Triazolam NanoTab For Procedural Sedation, Anxiolysis & Analgesia
• Transdel Pharmaceuticals Announces Positive Phase 3 Study Results For Lead Topical Pain Drug Ketotransdel(R)
• Positive Phase IIb Results For GSK1838262 (XP13512) Reported For Neuropathic Pain Associated With Post-Herpetic Neuralgia
• Orexo Announces Positive Phase III Results For KW-2246 In Japan
• AcelRx Announces Positive Phase 2 Results From A Study Of ARX-01 Sufentanil NanoTabs In Treating Post-Operative Pain
• VaxInnate Reports Positive Results From Preclinical Testing Of Swine Flu Vaccine Developed Using Novel Technology
• Nektar Announces Positive Results From Phase 2 Study Of Oral NKTR-118 In Patients With Opioid-Induced Constipation (OIC)
• EpiCept Announces Positive Results From Phase IIb Trial For EpiCeptTM NP-1
• Baxter Presents Clinical Efficacy Results From Phase III Study Of Seasonal Flu Vaccine
• SciClone And Sigma-Tau Announce Additional Positive Results In Clinical Study Examining ZADAXIN’s Ability To Enhance Response To H1N1 Vaccine
• SUMAVEL(TM) DosePro(TM) Available In The United States To Treat Acute Migraine And Cluster Headaches
• SciClone And Sigma-Tau Announce Positive Preliminary Results In Clinical Study Examining ZADAXIN’S Ability To Enhance Response To H1N1 Vaccine

Tags: acute, migraine, novel, nupathe, patch, phase, positive, results, transdermal, zelrix

This entry was posted on Friday, August 14th, 2009 at 12:08 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.